Celea Therapeutics

Melius Pharma

The company develops pharmaceutical treatments for chronic cough in patients with idiopathic pulmonary fibrosis.

Calluna Pharma

This clinical-stage company develops monoclonal antibodies to treat inflammatory and fibrotic diseases for patients with conditions like idiopathic pulmonary fibrosis and chronic kidney disease.

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.

Promedior

This biotechnology company develops drug therapies to treat rare fibrotic diseases for patients with conditions such as idiopathic pulmonary fibrosis and myelofibrosis.

Origo Biopharma

This clinical-stage biotechnology company develops small molecule therapies targeting the transforming growth factor beta pathway to treat fibrosis and cancer in healthcare patients.

Curzion Pharmaceuticals

This biopharmaceutical company develops oral small molecule therapies to treat patients with rare fibrotic conditions like diffuse cutaneous systemic sclerosis.

MDI Therapeutics

This pharmaceutical company develops serpin-based therapies to treat patients with chronic fibrosis, inflammatory diseases and fibroproliferative disorders.

Contineum Therapeutics

This company develops oral small-molecule therapies for patients with inflammatory, fibrotic and neurological diseases, including idiopathic pulmonary fibrosis and progressive multiple sclerosis.